Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chu zhi Pan"'
Autor:
Yu jun Li, Chu zhi Pan, Chang quan Fang, Zhu xiang Zhao, Hui ling Chen, Peng hao Guo, Zi wen Zhao
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background The clonal spread of multiple drug-resistant Acinetobacter baumannii is an emerging problem in China. We analysed the molecular epidemiology of Acinetobacter baumanni isolates at three teaching hospitals and investigated the risk
Externí odkaz:
https://doaj.org/article/0492d00b11134979bad110b7767040ac
Autor:
Jin Ding, Hong-Yang Wang, Hui Liu, Dan Liu, Wei Dong, Na Ta, Guang-Zhi Jin, Jing Li, Chu-zhi Pan, Zhen-Guang Wang, Wei Zhong, Li Xu, Shi-Chao Li, Wen Sun
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467cc4287a451df53a4061fc6573dd96
https://doi.org/10.1158/1078-0432.22472793
https://doi.org/10.1158/1078-0432.22472793
Autor:
Jin Ding, Hong-Yang Wang, Hui Liu, Dan Liu, Wei Dong, Na Ta, Guang-Zhi Jin, Jing Li, Chu-zhi Pan, Zhen-Guang Wang, Wei Zhong, Li Xu, Shi-Chao Li, Wen Sun
Purpose:To identify a predictive biomarker of sorafenib for hepatocellular carcinoma personalized therapy.Experimental Design:The patients treated with or without sorafenib after hepatocellular carcinoma recurrence from multicenters were matched with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d09759df4adcadf49a509db110661ca
https://doi.org/10.1158/1078-0432.c.6528324
https://doi.org/10.1158/1078-0432.c.6528324
Autor:
Chu-zhi Pan, Yun-Qiang Tang, Zhongguo Zhou, Jian-Hong Fang, Jing Xu, Minshan Chen, Li Xu, Yaojun Zhang, Hui Liu, Chu-Xing Liu, Shi-Mei Zhuang, Limin Zheng, Jia-Lin Zheng, Jin Ding, Li-Ru Shang
Publikováno v:
Hepatology (Baltimore, Md.)References. 70(3)
Sorafenib is the most recommended first-line systemic therapy for advanced hepatocellular carcinoma (HCC). Yet there is no clinically applied biomarker for predicting sorafenib response. We have demonstrated that a vascular pattern, named VETC (Vesse
Autor:
Yu jun Li1 liyujun_0110@163.com, Chu zhi Pan2 fanshusi@163.com, Zi wen Zhao1 zhaozw@yeah.net, Zhu xiang Zhao1 zhaozhuxiang@126.com, Hui ling Chen3 huiling1515@163.com, Wei bo Lu1 luweibo-520@163.com
Publikováno v:
BMC Infectious Diseases. 2013, Vol. 13 Issue 1, p1-17. 17p. 1 Color Photograph, 1 Diagram, 5 Charts.
Publikováno v:
Respiratory Infections.
Background: We analysed the molecular epidemiology of Acinetobacter baumanni isolates at three teaching hospitals and investigated the risk factors, clinical features, and outcomes of hospital-acquired pneumonia caused by extensive drug-resistant Aci
Autor:
Zhu xiang Zhao, Zi wen Zhao, Peng hao Guo, Yu jun Li, Chu zhi Pan, Hui ling Chen, Chang quan Fang
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
Background The clonal spread of multiple drug-resistant Acinetobacter baumannii is an emerging problem in China. We analysed the molecular epidemiology of Acinetobacter baumanni isolates at three teaching hospitals and investigated the risk factors,
Publikováno v:
BMC Infectious Diseases
Background The clonal spread of Acinetobacter baumannii is a global problem, and carbapenems, such as imipenem, remain the first-choice agent against A. baumannii. Using synergy to enhance the antibiotic activity of carbapenems could be useful. Here,